Exploring the association between familial hemiplegic migraine genes ( CACNA1A , ATP1A2 and SCN1A ) with migraine and epilepsy: A UK Biobank exome-wide association study
Cephalalgia · 2025
DOI: 10.1177/03331024241306103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cephalalgia, 2025. Verfasst von Christian Staehr und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Health Aarhus University, Aarhus, Denmark. Hauptthemen laut MEDLINE: NAV1.1 Voltage-Gated Sodium Channel, Epilepsy, Calcium Channels, Sodium-Potassium-Exchanging ATPase. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Riisfort Fonden, Danish Cardiovascular Academy.
Abstract (Originalsprache)
Background
Familial hemiplegic migraine (FHM) types 1–3 are associated with protein-altering genetic variants in CACNA1A, ATP1A2 and SCN1A, respectively. These genes have also been linked to epilepsy. Previous studies primarily focused on phenotypes, examining genetic variants in individuals with characteristic FHM symptoms. This study aimed to investigate the association of FHM genetic variation with migraine and epilepsy, utilizing a genotype-first approach.
Methods
Whole-exome sequence data from 454,706 individuals from the UK Biobank were examined for self-reported and inpatient-diagnosed migraine and epilepsy. Carriers were compared with non-carriers in a burden analysis using logistic regression while accounting for age, biological sex and UK Biobank assessment center. A machine learning-based approach was employed to predict whether variants resulted in gain-of-function (GoF), loss-of-function (LoF) or neutral effects.
Results
Heterozygous carriers of GoF CACNA1A variants, LoF ATP1A2 variants or neutral SCN1A variants were at increased risk of migraine. Homozygous carriers of neutral SCN1A variants were also associated with migraine but these carriers showed a reduced disease risk of epilepsy.
Conclusions
Heterozygous genotypes in all three FHM genes were associated with migraine but not epilepsy in this genotype-focused study. Homozygous SCN1A genotypes also showed increased disease risk of migraine, yet these carriers were protected against epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedicine, Health Aarhus University, Aarhus, Denmark.
- Department of Anesthesiology and Intensive Care Medicine, Aarhus University Hospital, Aarhus, Denmark.
- Genomic Medicine, Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.
- Department of Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.
- Department of Neurology, Aalborg University Hospital, Aalborg, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
ORCID-Profile: Christian Staehr, Flemming W Bach, Palle Duun Rohde
Förderung
- Riisfort Fonden
- Danish Cardiovascular Academy
Zitieren
APA
Staehr, C., Nyegaard, M., Bach, F. W., Rohde, P. D., & Matchkov, V. V. (2025). Exploring the association between familial hemiplegic migraine genes ( CACNA1A , ATP1A2 and SCN1A ) with migraine and epilepsy: A UK Biobank exome-wide association study. Cephalalgia. https://doi.org/10.1177/03331024241306103
Vancouver
Staehr C, Nyegaard M, Bach FW, Rohde PD, Matchkov VV. Exploring the association between familial hemiplegic migraine genes ( CACNA1A , ATP1A2 and SCN1A ) with migraine and epilepsy: A UK Biobank exome-wide association study. Cephalalgia. 2025. doi:10.1177/03331024241306103
BibTeX
@article{Staehr2025,
author = {Staehr, Christian and Nyegaard, Mette and Bach, Flemming W and Rohde, Palle Duun and Matchkov, Vladimir V},
title = {Exploring the association between familial hemiplegic migraine genes ( CACNA1A , ATP1A2 and SCN1A ) with migraine and epilepsy: A UK Biobank exome-wide association study},
journal = {Cephalalgia},
year = {2025},
doi = {10.1177/03331024241306103}
}
EUVIMED